Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-22 Tax Withholding |
2025-07-24 4:59 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
31,866 | $0.4798 | 746,279 (Direct) |
View |
| 2025-07-22 Tax Withholding |
2025-07-24 4:58 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
126,950 | $0.4798 | 2,191,460 (Direct) |
View |
| 2025-07-22 Tax Withholding |
2025-07-24 4:57 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY |
31,866 | $0.4798 | 749,677 (Direct) |
View |
| 2025-07-22 Tax Withholding |
2025-07-24 4:56 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
31,866 | $0.4798 | 767,881 (Direct) |
View |
| 2025-07-22 Tax Withholding |
2025-07-24 4:55 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
6,708 | $0.4798 | 201,945 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director |
75,000 | $0 | 152,100 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
75,000 | $0 | 162,600 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director |
75,000 | $0 | 149,600 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
75,000 | $0 | 149,600 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
75,000 | $0 | 146,384 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director |
75,000 | $0 | 149,600 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director |
75,000 | $0 | 132,650 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-16 4:05 pm |
N/A 2035-06-11 |
SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director |
75,000 | $0 | 132,650 (Direct) |
View |
| 2025-05-24 Tax Withholding |
2025-05-28 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
723 | $0.4733 | 208,653 (Direct) |
View |
| 2025-05-24 Tax Withholding |
2025-05-28 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY |
1,433 | $0.4733 | 781,543 (Direct) |
View |
| 2025-05-24 Tax Withholding |
2025-05-28 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,792 | $0.4733 | 799,747 (Direct) |
View |
| 2025-05-24 Tax Withholding |
2025-05-28 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,792 | $0.4733 | 778,145 (Direct) |
View |
| 2025-05-24 Tax Withholding |
2025-05-28 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
7,488 | $0.4733 | 2,318,410 (Direct) |
View |
| 2025-04-22 Tax Withholding |
2025-04-24 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
31,866 | $0.7763 | 782,976 (Direct) |
View |
| 2025-04-22 Tax Withholding |
2025-04-24 4:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
31,866 | $0.7763 | 779,937 (Direct) |
View |
| 2025-04-22 Tax Withholding |
2025-04-24 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
126,950 | $0.7763 | 2,325,898 (Direct) |
View |
| 2025-04-22 Tax Withholding |
2025-04-24 4:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
31,866 | $0.7763 | 801,539 (Direct) |
View |
| 2025-04-22 Tax Withholding |
2025-04-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
6,708 | $0.7763 | 209,376 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:33 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
149,180 | $0 | 315,538 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
705 | $1 | 315,538 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
507 | $0.9561 | 315,538 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:32 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
680,000 | $0 | 1,393,405 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,792 | $1 | 1,393,405 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,513 | $0.9561 | 1,393,405 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:32 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
680,000 | $0 | 1,374,842 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,434 | $1 | 1,374,842 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,375 | $0.9561 | 1,374,842 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:31 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
680,000 | $0 | 1,371,803 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,792 | $1 | 1,371,803 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,375 | $0.9561 | 1,371,803 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:30 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
2,125,000 | $0 | 4,202,848 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:30 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
7,488 | $1 | 4,202,848 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:30 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
10,663 | $0.9561 | 4,202,848 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
30,456 | $1.15 | 167,570 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
129,593 | $1.15 | 716,710 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
129,549 | $1.15 | 697,651 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
129,242 | $1.15 | 694,970 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
412,584 | $1.15 | 2,095,999 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
721 | $1.88 | 201,863 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
505 | $1.94 | 201,863 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,430 | $1.88 | 827,200 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,371 | $1.94 | 827,200 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,787 | $1.88 | 841,303 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,508 | $1.94 | 841,303 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,787 | $1.88 | 824,212 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,371 | $1.94 | 824,212 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
7,473 | $1.88 | 2,508,583 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
10,642 | $1.94 | 2,508,583 (Direct) |
View |
Ownership |
2024-10-28 4:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
0 | $0 | 380,002 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:38 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
2,801 | $0.86 | 830,001 (Direct) |
View |